143 related articles for article (PubMed ID: 37795222)
21. Definitive radiotherapy for early glottic carcinoma: prognostic factors and implications for treatment.
Burke LS; Greven KM; McGuirt WT; Case D; Hoen HM; Raben M
Int J Radiat Oncol Biol Phys; 1997 Apr; 38(1):37-42. PubMed ID: 9212002
[TBL] [Abstract][Full Text] [Related]
22. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial.
Widmark A; Gunnlaugsson A; Beckman L; Thellenberg-Karlsson C; Hoyer M; Lagerlund M; Kindblom J; Ginman C; Johansson B; Björnlinger K; Seke M; Agrup M; Fransson P; Tavelin B; Norman D; Zackrisson B; Anderson H; Kjellén E; Franzén L; Nilsson P
Lancet; 2019 Aug; 394(10196):385-395. PubMed ID: 31227373
[TBL] [Abstract][Full Text] [Related]
23. T1 Glottic Cancer: Does Anterior Commissure Involvement Worsen Prognosis?
Mannelli G; Comini LV; Santoro R; Bettiol A; Vannacci A; Desideri I; Bonomo P; Piazza C
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32517265
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of acute/late toxicity and local recurrence in T1-T2 glottic carcinoma treated with accelerated hypofractionated 3D-conformal external beam radiotherapy (3D-CRT).
Kouloulias VE; Zygogianni A; Mosa E; Platoni K; Georgakopoulos J; Antypas C; Beli I; Tolia M; Maragoudakis P; Giotakis I; Papas Z; Psyrri A; Kelekis N; Kouvaris J
Radiol Oncol; 2013 Jun; 47(2):185-91. PubMed ID: 23801916
[TBL] [Abstract][Full Text] [Related]
25. Radiotherapy for patients with early-stage glottic carcinoma: univariate and multivariate analyses in a group of consecutive, unselected patients.
Franchin G; Minatel E; Gobitti C; Talamini R; Vaccher E; Sartor G; Politi D; Trovò MG; Barzan L
Cancer; 2003 Aug; 98(4):765-72. PubMed ID: 12910521
[TBL] [Abstract][Full Text] [Related]
26. Definitive radiotherapy for early glottic carcinoma: prognostic factors and implications for treatment.
Burke LS; Greven KM; McGuirt WT; Case D; Hoen HM; Raben M
Int J Radiat Oncol Biol Phys; 1997 Jul; 38(5):1001-6. PubMed ID: 9276365
[TBL] [Abstract][Full Text] [Related]
27. Prognostic factors in patients with T1 glottic cancer treated with radiotherapy.
Mucha-Małecka A; Chrostowska A; Urbanek K; Małecki K
Strahlenther Onkol; 2019 Sep; 195(9):792-804. PubMed ID: 31214734
[TBL] [Abstract][Full Text] [Related]
28. Outcomes of radiation therapy for T1 glottic carcinoma from an Italian regional series with doses ranging from 60 to 66 Gy.
Manzo R; Ravo V; Murino P; Morra A; Panetti G; Laudati A; Prisco A; Panelli G; Muto P
Tumori; 2010; 96(4):577-81. PubMed ID: 20968137
[TBL] [Abstract][Full Text] [Related]
29. Treatment results of carcinoma in situ of the glottis: an analysis of 82 cases.
Le QT; Takamiya R; Shu HK; Smitt M; Singer M; Terris DJ; Fee WE; Goffinet DR; Fu KK
Arch Otolaryngol Head Neck Surg; 2000 Nov; 126(11):1305-12. PubMed ID: 11074826
[TBL] [Abstract][Full Text] [Related]
30. Hypofractionated radiotherapy and surgery compared to standard radiotherapy in early glottic cancer.
Kim KN; Dyer MA; Qureshi MM; Shah NK; Grillone GA; Faden DL; Jalisi SM; Truong MT
Am J Otolaryngol; 2020; 41(5):102544. PubMed ID: 32505989
[TBL] [Abstract][Full Text] [Related]
31. Hypofractionated radiotherapy for early stage glottic cancer: efficacy of 3.5 Gy per fraction.
Lee TH; Lee JH; Kwon SK; Chung EJ; Wu HG
Radiat Oncol J; 2022 Jun; 40(2):120-126. PubMed ID: 35796115
[TBL] [Abstract][Full Text] [Related]
32. Long-Term Outcome of Definitive Radiotherapy for Early Glottic Cancer: Prognostic Factors and Patterns of Local Failure.
Lim YJ; Wu HG; Kwon TK; Hah JH; Sung MW; Kim KH; Park CI
Cancer Res Treat; 2015 Oct; 47(4):862-70. PubMed ID: 25687859
[TBL] [Abstract][Full Text] [Related]
33. Prognostic factors for local control in patients receiving radiation therapy for early glottic cancer: anterior commissure involvement and effect of chemoradiotherapy.
Kitani Y; Kubota A; Furukawa M; Sato K
Eur Arch Otorhinolaryngol; 2016 Apr; 273(4):1011-7. PubMed ID: 25726168
[TBL] [Abstract][Full Text] [Related]
34. Treatment results and prognostic factors of advanced T3--4 laryngeal carcinoma: the University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience.
Nguyen-Tan PF; Le QT; Quivey JM; Singer M; Terris DJ; Goffinet DR; Fu KK
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1172-80. PubMed ID: 11483326
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of the maximum standardized uptake value for the locoregional control in early glottic cancer.
Kim D; Ki Y; Joo J; Jeon H; Park D; Nam J; Kim W
Radiat Oncol J; 2021 Dec; 39(4):297-303. PubMed ID: 34986551
[TBL] [Abstract][Full Text] [Related]
36. Optimized treatment strategy of radiotherapy for early glottic squamous cell carcinomas: An initial analysis.
Kimura K; Itoh Y; Okada T; Kubota S; Kawamura M; Nakahara R; Oie Y; Kozai Y; Takase Y; Tsuzuki H; Nishio N; Hiramatsu M; Fujimoto Y; Mizutani T; Naganawa S
Nagoya J Med Sci; 2017 Aug; 79(3):331-338. PubMed ID: 28878438
[TBL] [Abstract][Full Text] [Related]
37. Definitive radiotherapy for early (T1-T2) glottic squamous cell carcinoma: a 20 year Cleveland Clinic experience.
Khan MK; Koyfman SA; Hunter GK; Reddy CA; Saxton JP
Radiat Oncol; 2012 Nov; 7():193. PubMed ID: 23164282
[TBL] [Abstract][Full Text] [Related]
38. Multifactorial analysis of local control and survival in patients with early glottic cancer.
Nomura T; Ishikawa J; Ohki M; Ohata A; Araki R; Kikuchi S
Laryngoscope; 2020 Jul; 130(7):1701-1706. PubMed ID: 31397901
[TBL] [Abstract][Full Text] [Related]
39. Conventional fractionation should not be the standard of care for T2 glottic cancer.
Dixon LM; Douglas CM; Shaukat SI; Garcez K; Lee LW; Sykes AJ; Thomson D; Slevin NJ
Radiat Oncol; 2017 Nov; 12(1):178. PubMed ID: 29137654
[TBL] [Abstract][Full Text] [Related]
40. Prognostic and Treatment Differences Between T1a and T1b Glottic Cancer.
Syal A; Lott DG; Zhang N; Karle WE
Laryngoscope; 2022 Nov; 132(11):2187-2193. PubMed ID: 35060629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
